Skip to Main Content

Paper Details

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis.
J Immunother Cancer
51
2020
Author NameAffiliation
Luc DirixMedical University of South Carolina
  • 1 - 1

Datasets

Release 1.2